Natural Killer Cell Therapy in Children with Relapsed Leukemia

BACKGROUND: Novel therapies are needed for children with relapsed or refractory leukemia. We therefore tested the safety and feasibility of haploidentical natural killer cell therapy in this patient population. PROCEDURE: Twenty-nine children who had relapsed or refractory leukemia were treated with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pediatr Blood Cancer
Asıl Yazarlar: Rubnitz, Jeffrey E., Inaba, Hiroto, Kang, Guolian, Gan, Kwan, Hartford, Christine, Triplett, Brandon M., Dallas, Mari, Shook, David, Gruber, Tanja, Pui, Ching-Hon, Leung, Wing
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634362/
https://ncbi.nlm.nih.gov/pubmed/25925135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25555
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller